IQVIA (IQV)
Combines healthcare intelligence and commercial technology with global clinical research services.
$267.92
vs last close−2.17 (−0.80%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,736 | 3,868 | 3,737 | 3,814 | 3,896 | 3,958 | 3,829 | 4,017 | 4,100 | 4,364 | 4,151 | 4,368 |
| Cost of revenue | 2,426 | 2,478 | 2,444 | 2,757 | 2,518 | 2,580 | 2,531 | 2,694 | 2,727 | 4,072 | 2,796 | 2,933 |
| Gross profit | 1,310 | 1,390 | 1,293 | 1,057 | 1,378 | 1,378 | 1,298 | 1,323 | 1,373 | 292 | 1,355 | 1,435 |
| 829 | 889 | 787 | 509 | 828 | 752 | 802 | 817 | 820 | −440 | 841 | 929 | |
| Selling, general & administrative | 502 | 556 | 508 | 509 | 522 | 453 | 508 | 509 | 514 | 468 | 502 | 574 |
| Other expenses | 327 | 333 | 279 | 0 | 306 | 299 | 294 | 308 | 306 | −908 | 339 | 355 |
| Operating income | 481 | 501 | 506 | 548 | 550 | 626 | 496 | 506 | 553 | 732 | 514 | 506 |
| −127 | −134 | −169 | −110 | −201 | −77 | −186 | −183 | −145 | −160 | −186 | −205 | |
| Interest income | 14 | 12 | 11 | 12 | 13 | 11 | 11 | 10 | 13 | 11 | 6 | 7 |
| Interest expense | 181 | 181 | 166 | 163 | 170 | 171 | 165 | 182 | 189 | 193 | 192 | 197 |
| Other non-operating income | −49 | −53 | 3 | −66 | 31 | −89 | 8 | 1 | −44 | 2 | −6 | 8 |
| Income before tax | 354 | 367 | 337 | 438 | 350 | 549 | 310 | 323 | 408 | 572 | 328 | 301 |
| Income tax expense | 51 | −102 | 49 | 75 | 65 | 112 | 61 | 57 | 76 | 58 | 59 | 60 |
| Net income from continuing operations | 303 | 469 | 288 | 363 | 285 | 437 | 249 | 266 | 332 | 514 | 269 | 241 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −2 | 0 | 0 | 17 |
| Net income | 303 | 469 | 288 | 363 | 285 | 437 | 249 | 266 | 331 | 514 | 274 | 256 |
| EPS, basic | $1.66 | $2.58 | $1.58 | $1.99 | $1.57 | $2.44 | $1.42 | $1.55 | $1.94 | $3.02 | $1.63 | $1.54 |
| EPS, diluted | $1.63 | $2.54 | $1.56 | $1.97 | $1.55 | $2.42 | $1.40 | $1.54 | $1.93 | $2.99 | $1.61 | $1.53 |
| Weighted average shares, basic | 183 | 182 | 182 | 182 | 182 | 179 | 176 | 172 | 170 | 170 | 168 | 167 |
| Weighted average shares, diluted | 186 | 184 | 184 | 184 | 184 | 181 | 177 | 173 | 172 | 172 | 170 | 169 |
| EBITDA | 827 | 870 | 767 | 883 | 797 | 1,018 | 753 | 781 | 883 | 1,047 | 808 | 790 |
| Depreciation & amortization | 297 | 316 | 264 | 269 | 278 | 303 | 265 | 276 | 286 | 317 | 288 | 292 |
| EBIT | 530 | 554 | 503 | 614 | 519 | 715 | 488 | 505 | 597 | 730 | 520 | 498 |